|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Laryngospasm | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Laryngismus | |||||
| 3 | More general conditions related to this trial | ||||
| Laryngeal Diseases | |||||
| Otorhinolaryngologic Diseases | |||||
| Respiration Disorders | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| sevoflurane | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anesthetics | |||||
| Anesthetics, General | |||||
| Anesthetics, Inhalation | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Hematologic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Platelet Aggregation Inhibitors | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| University Hospital, Basel, Switzerland | |||||